地拉罗司、DEFERASIROX(商品名 JADENU)口服铁螯合剂、美国上市、一次性进口、平价供应
英文名：DEFERASIROX
商标名：JADENU
中文名：地拉罗司
剂 型：分散片、颗粒
生产商：诺华
包装规格[注：除下面价格以外，运费另加500元人民币]
JADENU SPRINKLE 90MG GRN 30 Generic NameDEFERASIROX NOVARTIS PHARM CORP NDC:78072715 $1,495.72
JADENU SPRINKLE 180MG GRN 30 Generic NameDEFERASIROX NOVARTIS PHARM CORP NDC:78071315 $2,991.40
JADENU SPRINKLE 360MG GRN 30 Generic NameDEFERASIROX NOVARTIS PHARM CORP NDC:78072015 $5,982.68
JADENU 180MG TAB 30/EA DEFERASIROX NOVARTIS NDC:00078-0655-15 $3,932.46
JADENU 360MG TAB 30/EA DEFERASIROX NOVARTIS NDC:00078-0656-15 $7,064.81
JADENU 90MG TAB 30/EA DEFERASIROX NOVARTIS NDC:00078-0654-15 $3,932.46
JADENU SPRINKLE 180MG 30/EA DEFERASIROX NOVARTIS NDC:00078-0713-15 $3,932.46
JADENU SPRINKLE 360MG 30/EA DEFERASIROX NOVARTIS NDC:00078-0720-15 $7,064.81
JADENU SPRINKLE 90MG 30/EA DEFERASIROX NOVARTIS NDC:00078-0727-15 $2,466.26
---------------------------------------------------
JADENU® (deferasirox)
INDICATION
Treatment of Chronic Iron Overload Due to Blood Transfusions (Transfusional Iron Overload)
JADENU® (deferasirox) tablets for oral use and JADENU® Sprinkle (deferasirox) granules are indicated for the treatment of chronically elevated levels of iron in the blood caused by repeated blood transfusions (transfusional hemosiderosis) in patients 2 years of age and older.
Limitations on the Use of JADENU
It is not known if JADENU is safe or effective when taken with another therapy that lowers iron levels in the blood
Patients who have a serious blood disorder known as myelodysplastic syndromes (MDS) may take JADENU to treat chronically elevated levels of iron in the blood caused by repeated blood transfusions. The iron-lowering effects and safety of JADENU have not been studied in clinical trials specifically designed for just these patients with MDS
IMPORTANT SAFETY INFORMATION for JADENU® (deferasirox) tablets for oral use and JADENU® Sprinkle (deferasirox) granules
What is the most important safety information to know about JADENU?
JADENU contains deferasirox, the same active ingredient in EXJADE® (deferasirox) tablets for oral suspension. Deferasirox may cause serious kidney problems, liver problems, and bleeding in the stomach or intestines. In some cases, these problems were fatal. Kidney problems occurred particularly in patients with multiple medical conditions and those who were very ill because of their disease. Bleeding in the stomach or intestines occurred more often in elderly patients. Liver problems were more likely to happen in patients older than 55 years.
Your doctor should check your kidney function with blood tests and urinalyses:
Before taking JADENU
Monthly during treatment
If you already have a history of kidney problems or are at risk for kidney problems, your doctor should check your kidneys:
Every week for the first month
Monthly during treatment
Your doctor should check your liver function with blood tests:
Before taking JADENU
Every other week for the first month after starting JADENU
Monthly during treatment
You should not take JADENU if you have:
Certain kinds of kidney problems
Preexisting severe liver problems
High-risk MDS
Advanc |
